title: Metabolic ketoacidosis with normal blood glucose: A rare complication of sodium-glucose cotransporter 2 inhibitors.
abstract: Ketoacidosis is a significant and often a life-threatening complication of diabetes mellitus seen mostly in type 1 diabetes mellitus as well as occasionally in type 2 diabetes mellitus. Diabetic ketoacidosis usually manifests with high blood glucose more than 250 mg/dL, but euglycemic diabetic ketoacidosis is defined as ketoacidosis associated with blood glucose level less than 250 mg/dL. Normal blood glucose in such patients results in significant delay in diagnosis and management of diabetic ketoacidosis, thus increasing mortality and morbidity. We present a case of euglycemic diabetic ketoacidosis secondary to canagliflozin in a type 2 diabetic patient.
authors.affiliation: Department of Internal Medicine, Temple University/Conemaugh Memorial Hospital, Johnstown, PA, USA.
authors.forename: Saad
authors.initials: S
authors.lastname: Ullah
authors.affiliation: Department of Internal Medicine, Temple University/Conemaugh Memorial Hospital, Johnstown, PA, USA.
authors.forename: Noman
authors.initials: N
authors.lastname: Khan
authors.affiliation: Department of Internal Medicine, Temple University/Conemaugh Memorial Hospital, Johnstown, PA, USA.
authors.forename: Hassan
authors.initials: H
authors.lastname: Zeb
authors.affiliation: Department of Internal Medicine, Temple University/Conemaugh Memorial Hospital, Johnstown, PA, USA.
authors.forename: Hassan
authors.initials: H
authors.lastname: Tahir
keywords: Diabetes/endocrinology; canagliflozin; diabetic ketoacidosis; euglycemic; metabolic acidosis